Fetal and maternal endocrine responses to reduced uteroplacental blood flow.
In clinical practice, falling or reduced maternal estrogen levels are commonly regarded as indicators of fetal distress. However, experimental studies in primate animal models demonstrate that changes in maternal estradiol concentrations vary in response to reduced uteroplacental blood flow and are elevated during fetal hypoxemic stress, suggesting an increase in fetal adrenal precursor steroids. We studied the effects of graded reductions in maternal distal aortic blood flow (Qda) on the fetal MCR of dehydroepiandrosterone (D; MCR-D), the fetal production rate of D (PR-D), and changes in maternal and fetal plasma concentrations of D, D sulfate, cortisol, androstenedione, estrone (E1), and estradiol (E2) and in fetal plasma ACTH, PRL, and LH. A continuous i.v. infusion of [7-3H]D was administered to fetuses in five pregnant baboons (Papio anubis) at 155-165 days gestation (term, 184 days) for 270 min. A 50% reduction in mean distal aortic blood flow was imposed after 60 min by means of partial occlusion of the aorta with a snare device, which was released at 180 min. Maternal and fetal blood samples were collected at 10-min intervals from 30-60, 120-180, and 240-270 min. Equilibrium concentrations of [3H]D in fetal plasma were determined, and the MCR-D and PR-D were calculated for each of the three levels of Qda corresponding to the control, occlusion, and release intervals. Concentrations of steroid and peptide hormones in maternal and fetal plasma were determined by RIA, and arterial blood pH, pO2, and pCO2 were measured. Control fetal PR-D (mean +/- SE, 4.4 +/- 2.0 mg/day) rose significantly during aortic occlusion accompanied by fetal hypoxemia (11.8 +/- 3.1 mg/day; P less than 0.05) and remained elevated with release of the aortic constriction (13.8 +/- 2.9 mg/day). Changes in fetal MCR-D were variable and not statistically significant. Among the maternal plasma steroids, only E1 and E2 increased significantly, doubling from control values during aortic occlusion and increasing by another 50% after release (P less than 0.05). There was a significant correlation between fetal PR-D and maternal plasma E2 and E1 concentrations (r2 = 0.76 and 0.71, respectively; P less than 0.01). Fetal hypoxemia was associated with dramatic increases in fetal plasma D, D sulfate, androstenedione, E1, and E2. No significant change occurred in fetal plasma cortisol, which tended to decline throughout the study. We observed a dramatic and sustained increase in fetal plasma ACTH during the period of reduced Qda and for 90 min thereafter, but no change in PRL or LH.(ABSTRACT TRUNCATED AT 400 WORDS)
Shepherd
R W
RW
Division of Reproductive Biology and Behavior, Oregon Regional Primate Research Center, Beaverton 97006.
Stanczyk
F Z
FZ
Bethea
C L
CL
Novy
M J
MJ
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000728:Androgens / Q000097:blood; D000818:Animals; D003326:Coronary Circulation; D003687:Dehydroepiandrosterone / Q000097:blood; D004702:Endocrine Glands / Q000502:physiology*; D004958:Estradiol / Q000097:blood; D005260:Female; D005315:Fetal Diseases / Q000097:blood*; D006854:Hydrocortisone / Q000097:blood; D000860:Hypoxia / Q000097:blood*; D007986:Luteinizing Hormone / Q000097:blood; D008431:Maternal-Fetal Exchange / Q000502:physiology*; D010215:Papio; D010920:Placenta / Q000098:blood supply*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood; D012039:Regional Blood Flow
D000728:Androgens; D003687:Dehydroepiandrosterone; D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D006854:Hydrocortisone